Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics:

• Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00)
• Emerging JAK inhibitors under Phase III evaluation for MF (6:59)
• Current guidelines and strategies for managing MF (13:53)
• Emerging data with novel agents and strategies for MF (17:31)
• Splenic response and symptomology in patients with MF (25:36)

CME information and select publications